Caplin Point Laboratories Limited Stock NSE India S.E.
Equities
CAPLIPOINT
INE475E01026
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,336 INR | +0.10% | +1.50% | -1.49% |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Mar. 28 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
Sales 2024 * | 16.92B 203M | Sales 2025 * | 19.11B 229M | Capitalization | 101B 1.21B |
---|---|---|---|---|---|
Net income 2024 * | 4.57B 54.87M | Net income 2025 * | 4.17B 50.08M | EV / Sales 2024 * | 5.98 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.29 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
20.7
x | Employees | 1,642 |
Yield 2024 * |
0.24% | Yield 2025 * |
0.26% | Free-Float | 25.33% |
Latest transcript on Caplin Point Laboratories Limited
1 day | +0.10% | ||
1 week | +1.50% | ||
Current month | +1.57% | ||
1 month | +5.30% | ||
3 months | -11.18% | ||
6 months | +33.95% | ||
Current year | -1.49% |
Managers | Title | Age | Since |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 15-03-27 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 16-02-18 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 10-11-30 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 15-03-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1,336 | +0.10% | 50 158 |
24-04-23 | 1,335 | -0.24% | 64,347 |
24-04-22 | 1,338 | +2.00% | 74,419 |
24-04-19 | 1,312 | -0.36% | 72,593 |
24-04-18 | 1,316 | +0.02% | 102,719 |
Delayed Quote NSE India S.E., April 24, 2024 at 07:40 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.97% | 42.77B | |
+20.21% | 22.23B | |
+12.68% | 14.44B | |
+12.19% | 13.05B | |
+35.45% | 11.59B | |
-8.80% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+5.03% | 4.97B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- CAPLIPOINT Stock